Advancing Precision Medicine in South Tyrol, Italy: A Public Health Development Proposal for a Bilingual, Autonomous Province
Abstract
:1. Introduction
2. Precision Medicine and Public Health
2.1. Components of Precision Medicine
2.2. Precision Medicine at the Bedside
2.3. Optimizing Population Health
3. Challenges in the Development of Precision Medicine in South Tyrol
3.1. Language, Cultural Barriers, and Workforce Shortages
3.2. Lack of Infrastructure and Limited Digitalization
4. Development Program for Precision Medicine in South Tyrol
4.1. Proposal
4.1.1. Pharmacogenomics
4.1.2. Partnership with Local Research Institution and University
4.1.3. Partnership with National and International Universities and Research Institutions
4.2. Infrastructure
5. Discussion
6. Conclusions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- National Research Council; Committee on a Framework for Developing a New Taxonomy of Disease. Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease; National Academies Press: Washington, DC, USA, 2011; ISBN 0-309-22225-7. [Google Scholar]
- Rosenquist, R.; Cuppen, E.; Buettner, R.; Caldas, C.; Dreau, H.; Elemento, O.; Frederix, G.; Grimmond, S.; Haferlach, T.; Jobanputra, V.; et al. Clinical Utility of Whole-Genome Sequencing in Precision Oncology. Semin. Cancer Biol. 2022, 84, 32–39. [Google Scholar] [CrossRef] [PubMed]
- Bilkey, G.A.; Burns, B.L.; Coles, E.P.; Mahede, T.; Baynam, G.; Nowak, K.J. Optimizing Precision Medicine for Public Health. Front. Public Health 2019, 7, 42. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Strianese, O.; Rizzo, F.; Ciccarelli, M.; Galasso, G.; D’Agostino, Y.; Salvati, A.; Del Giudice, C.; Tesorio, P.; Rusciano, M.R. Precision and Personalized Medicine: How Genomic Approach Improves the Management of Cardiovascular and Neurodegenerative Disease. Genes 2020, 11, 747. [Google Scholar] [CrossRef]
- Traversi, D.; Pulliero, A.; Izzotti, A.; Franchitti, E.; Iacoviello, L.; Gianfagna, F.; Gialluisi, A.; Izzi, B.; Agodi, A.; Barchitta, M.; et al. Precision Medicine and Public Health: New Challenges for Effective and Sustainable Health. J. Pers. Med. 2021, 11, 135. [Google Scholar] [CrossRef]
- Jooma, S.; Hahn, M.J.; Hindorff, L.A.; Bonham, V.L. Defining and Achieving Health Equity in Genomic Medicine. Ethn. Dis. 2019, 29, 173–178. [Google Scholar] [CrossRef] [PubMed]
- Mazzucco, W.; Pastorino, R.; Lagerberg, T.; Colotto, M.; d’Andrea, E.; Marotta, C.; Marzuillo, C.; Villari, P.; Federici, A.; Ricciardi, W. Current State of Genomic Policies in Healthcare among EU Member States: Results of a Survey of Chief Medical Officers. Eur. J. Public Health 2017, 27, 931–937. [Google Scholar] [CrossRef] [Green Version]
- Simone, B.; Mazzucco, W.; Gualano, M.R.; Agodi, A.; Coviello, D.; Bricarelli, F.D.; Dallapiccola, B.; Di Maria, E.; Federici, A.; Genuardi, M. The Policy of Public Health Genomics in Italy. Health Policy 2013, 110, 214–219. [Google Scholar] [CrossRef]
- Boccia, S.; Federici, A.; Siliquini, R.; Calabrò, G.E.; Ricciardi, W. Implementation of Genomic Policies in Italy: The New National Plan for Innovation of the Health System Based on Omics Sciences. Epidemiol. Biostat. Public Health 2017, 14. [Google Scholar] [CrossRef] [PubMed]
- Ministero Della Salute Piano Nazionale Della Prevenzione 2020–2025. Available online: https://www.salute.gov.it/imgs/C_17_notizie_5029_0_file.pdf (accessed on 22 March 2023).
- Tanner, M. The Grass Is Not Always Greener: A Look at National Health Care Systems around the World. Cato Policy Anal. Pap. 2008, 613, 1–48. [Google Scholar] [CrossRef] [Green Version]
- Peterlini, O. The South-Tyrol Autonomy in Italy: Historical, Political and Legal Aspects. In One Country, Two Systems, Three Legal Orders—Perspectives of Evolution; Springer: Berlin/Heidelberg, Germany, 2009; ISBN 978-3-540-68571-5. [Google Scholar]
- Riehl, C.M.; Hajek, J. Language Policy and Reality in South Tyrol. In Uniformity in Diversity in Language Policy: Global Perspectives; Multilingual Matters: Toronto, Canada, 2011; pp. 210–225. [Google Scholar]
- Eichinger, L. South Tyrol: German and Italian in a Changing World. J. Multiling. Multicult. Dev. 2002, 23, 137–149. [Google Scholar] [CrossRef] [Green Version]
- Fink, R.L.; Robinson, R.K.; Wyld, D.C. English-Only Work Rules: Balancing Fair Employment Considerations in a Multicultural and Multilingual Healthcare Workforce. J. Healthc. 1996, 41, 473. [Google Scholar]
- Valeriani, G.; Sarajlic Vukovic, I.; Lindegaard, T.; Felizia, R.; Mollica, R.; Andersson, G. Addressing Healthcare Gaps in Sweden during the COVID-19 Outbreak: On Community Outreach and Empowering Ethnic Minority Groups in a Digitalized Context. Healthcare 2020, 8, 445. [Google Scholar] [CrossRef] [PubMed]
- Zillner, S.; Oberkampf, H.; Bretschneider, C.; Zaveri, A.; Faix, W.; Neururer, S. Towards a Technology Roadmap for Big Data Applications in the Healthcare Domain. In Proceedings of the 2014 IEEE 15th International Conference on Information Reuse and Integration (IEEE IRI 2014), Redwood City, CA, USA, 13–15 August 2014; pp. 291–296. [Google Scholar]
- Ginsburg, G.S.; Phillips, K.A. Precision Medicine: From Science to Value. Health Aff. 2018, 37, 694–701. [Google Scholar] [CrossRef]
- Fernandez-Rozadilla, C.; Simões, A.R.; Lleonart, M.E.; Carnero, A.; Carracedo, Á. Tumor Profiling at the Service of Cancer Therapy. Front. Oncol. 2020, 10, 595613. [Google Scholar] [CrossRef]
- Aleksakhina, S.N.; Imyanitov, E.N. Cancer Therapy Guided by Mutation Tests: Current Status and Perspectives. Int. J. Mol. Sci. 2021, 22, 10931. [Google Scholar] [CrossRef]
- Shaaban, S.; Ji, Y. Pharmacogenomics and Health Disparities, Are We Helping? Front. Genet. 2023, 14, 1099541. [Google Scholar] [CrossRef]
- Sethi, Y.; Patel, N.; Kaka, N.; Kaiwan, O.; Kar, J.; Moinuddin, A.; Goel, A.; Chopra, H.; Cavalu, S. Precision Medicine and the Future of Cardiovascular Diseases: A Clinically Oriented Comprehensive Review. J. Clin. Med. 2023, 12, 1799. [Google Scholar] [CrossRef]
- Espay, A.J. Models of Precision Medicine for Neurodegeneration. Handb. Clin. Neurol. 2023, 192, 21–34. [Google Scholar] [CrossRef]
- Zandl-Lang, M.; Plecko, B.; Köfeler, H. Lipidomics-Paving the Road towards Better Insight and Precision Medicine in Rare Metabolic Diseases. Int. J. Mol. Sci. 2023, 24, 1709. [Google Scholar] [CrossRef]
- Amaral, M.D. Precision Medicine for Rare Diseases: The Times They Are A-Changin’. Curr. Opin. Pharm. 2022, 63, 102201. [Google Scholar] [CrossRef] [PubMed]
- OECD. New Health Technologies: Managing Access, Value and Sustainability. In New Health Technologies: Managing Access, Value and Sustainability; OECD Publishing: Paris, France, 2017. [Google Scholar] [CrossRef]
- Downie, L.; Halliday, J.; Lewis, S.; Amor, D.J. Principles of Genomic Newborn Screening Programs: A Systematic Review. JAMA Netw. Open. 2021, 4, e2114336. [Google Scholar] [CrossRef]
- Evans, O.; Gaba, F.; Manchanda, R. Population-Based Genetic Testing for Women’s Cancer Prevention. Best Pract. Res. Clin. Obstet. Gynaecol. 2020, 65, 139–153. [Google Scholar] [CrossRef] [PubMed]
- Kurnat-Thoma, E. Educational and Ethical Considerations for Genetic Test Implementation within Health Care Systems. Netw. Syst. Med. 2020, 3, 58–66. [Google Scholar] [CrossRef]
- Kwame, A.; Petrucka, P.M. A Literature-Based Study of Patient-Centered Care and Communication in Nurse-Patient Interactions: Barriers, Facilitators, and the Way Forward. BMC Nurs. 2021, 20, 158. [Google Scholar] [CrossRef]
- Ortega, P.; Prada, J. Words Matter: Translanguaging in Medical Communication Skills Training. Perspect. Med. Educ. 2020, 9, 251–255. [Google Scholar] [CrossRef] [PubMed]
- Cometto, G.; Buchan, J.; Dussault, G. Developing the Health Workforce for Universal Health Coverage. Bull. World Health Organ. 2020, 98, 109–116. [Google Scholar] [CrossRef]
- Kwon, H.; Jung, E.-Y. The Impact of Policy on the Growth of Precision Medicine. Health Policy Technol. 2018, 7, 347–357. [Google Scholar] [CrossRef]
- Ahmed, Z.; Mohamed, K.; Zeeshan, S.; Dong, X. Artificial Intelligence with Multi-Functional Machine Learning Platform Development for Better Healthcare and Precision Medicine. Database 2020, 2020, baaa010. [Google Scholar] [CrossRef]
- Lehne, M.; Sass, J.; Essenwanger, A.; Schepers, J.; Thun, S. Why Digital Medicine Depends on Interoperability. NPJ Digit. Med. 2019, 2, 79. [Google Scholar] [CrossRef] [Green Version]
- Gaudet-Blavignac, C.; Raisaro, J.L.; Touré, V.; Österle, S.; Crameri, K.; Lovis, C. A National, Semantic-Driven, Three-Pillar Strategy to Enable Health Data Secondary Usage Interoperability for Research Within the Swiss Personalized Health Network: Methodological Study. JMIR Med. Inform. 2021, 9, e27591. [Google Scholar] [CrossRef]
- Luh, F.; Yen, Y. Cybersecurity in Science and Medicine: Threats and Challenges. Trends Biotechnol. 2020, 38, 825–828. [Google Scholar] [CrossRef] [PubMed]
- Chow-White, P.A.; MacAulay, M.; Charters, A.; Chow, P. From the Bench to the Bedside in the Big Data Age: Ethics and Practices of Consent and Privacy for Clinical Genomics and Personalized Medicine. Ethics Inf. Technol. 2015, 17, 189–200. [Google Scholar] [CrossRef]
- Südtiroler Sanitätsbetrieb. Personalisierte Medizin im Südtiroler Sanitätsbetrieb. Available online: https://www.sabes.it/de/news/personalisierte-medizin-im-sudtiroler-sanitatsbetrieb (accessed on 24 March 2023).
- Pattaro, C.; Gögele, M.; Mascalzoni, D.; Melotti, R.; Schwienbacher, C.; De Grandi, A.; Foco, L.; D’Elia, Y.; Linder, B.; Fuchsberger, C.; et al. The Cooperative Health Research in South Tyrol (CHRIS) Study: Rationale, Objectives, and Preliminary Results. J. Transl. Med. 2015, 13, 348. [Google Scholar] [CrossRef]
- Murgia, F.; Melotti, R.; Foco, L.; Gögele, M.; Meraviglia, V.; Motta, B.; Steger, A.; Toifl, M.; Sinnecker, D.; Müller, A.; et al. Effects of Smoking Status, History and Intensity on Heart Rate Variability in the General Population: The CHRIS Study. PLoS ONE 2019, 14, e0215053. [Google Scholar] [CrossRef]
- Castelo Rueda, M.P.; Raftopoulou, A.; Gögele, M.; Borsche, M.; Emmert, D.; Fuchsberger, C.; Hantikainen, E.M.; Vukovic, V.; Klein, C.; Pramstaller, P.P.; et al. Frequency of Heterozygous Parkin (PRKN) Variants and Penetrance of Parkinson’s Disease Risk Markers in the Population-Based CHRIS Cohort. Front. Neurol. 2021, 12, 706145. [Google Scholar] [CrossRef]
- Emmert, D.B.; Vukovic, V.; Dordevic, N.; Weichenberger, C.X.; Losi, C.; D’Elia, Y.; Volpato, C.; Hernandes, V.V.; Gögele, M.; Foco, L.; et al. Genetic and Metabolic Determinants of Atrial Fibrillation in a General Population Sample: The CHRIS Study. Biomolecules 2021, 11, 1663. [Google Scholar] [CrossRef] [PubMed]
- Fazzini, F.; Lamina, C.; Raftopoulou, A.; Koller, A.; Fuchsberger, C.; Pattaro, C.; Del Greco, F.M.; Döttelmayer, P.; Fendt, L.; Fritz, J.; et al. Association of Mitochondrial DNA Copy Number with Metabolic Syndrome and Type 2 Diabetes in 14 176 Individuals. J. Intern. Med. 2021, 290, 190–202. [Google Scholar] [CrossRef]
- König, E.; Rainer, J.; Hernandes, V.V.; Paglia, G.; Del Greco, M.F.; Bottigliengo, D.; Yin, X.; Chan, L.S.; Teumer, A.; Pramstaller, P.P.; et al. Whole Exome Sequencing Enhanced Imputation Identifies 85 Metabolite Associations in the Alpine CHRIS Cohort. Metabolites 2022, 12, 604. [Google Scholar] [CrossRef]
- Pattaro, C.; Barbieri, G.; Foco, L.; Weichenberger, C.X.; Biasiotto, R.; De Grandi, A.; Fuchsberger, C.; Egger, C.; Amon, V.S.C.; Hicks, A.A.; et al. Prospective Epidemiological, Molecular, and Genetic Characterization of a Novel Coronavirus Disease in the Val Venosta/Vinschgau: The CHRIS COVID-19 Study Protocol. Pathog. Glob. Health 2022, 116, 128–136. [Google Scholar] [CrossRef]
- Vukovic, V.; Hantikainen, E.; Raftopoulou, A.; Gögele, M.; Rainer, J.; Domingues, F.S.; Pramstaller, P.P.; Garcia-Larsen, V.; Pattaro, C. Association of Dietary Proteins with Serum Creatinine and Estimated Glomerular Filtration Rate in a General Population Sample: The CHRIS Study. J. Nephrol. 2023, 36, 103–114. [Google Scholar] [CrossRef]
- Cenamor, J.; Sjödin, D.R.; Parida, V. Adopting a Platform Approach in Servitization: Leveraging the Value of Digitalization. Int. J. Prod. Econ. 2017, 192, 54–65. [Google Scholar] [CrossRef]
- Innovation Teching Research Service Südtiroler Fond Zur Förderung Der Wissenschaftlichen Forschung (SFPR). Available online: https://home.sabes.it/de/forschungsfond.asp (accessed on 25 March 2023).
- Mateo, J.; McKay, R.; Abida, W.; Aggarwal, R.; Alumkal, J.; Alva, A.; Feng, F.; Gao, X.; Graff, J.; Hussain, M.; et al. Accelerating Precision Medicine in Metastatic Prostate Cancer. Nat. Cancer 2020, 1, 1041–1053. [Google Scholar] [CrossRef] [PubMed]
- Mattioli, A. La fuga dei cervelli: Ogni anno se ne vanno 1.500 altoatesini—Cronaca—Alto Adige. 2019. Available online: https://www.altoadige.it/cronaca/la-fuga-dei-cervelli-ogni-anno-se-ne-vanno-1-500-altoatesini-1.1950500 (accessed on 22 March 2023).
- Brunetti, F.; Matt, D.T.; Bonfanti, A.; De Longhi, A.; Pedrini, G.; Orzes, G. Digital Transformation Challenges: Strategies Emerging from a Multi-Stakeholder Approach. TQM J. 2020, 32, 697–724. [Google Scholar] [CrossRef]
- Mascalzoni, D.; Melotti, R.; Pattaro, C.; Pramstaller, P.P.; Gögele, M.; De Grandi, A.; Biasiotto, R. Ten Years of Dynamic Consent in the CHRIS Study: Informed Consent as a Dynamic Process. Eur. J. Hum. Genet. 2022, 30, 1391–1397. [Google Scholar] [CrossRef] [PubMed]
- Mascalzoni, D.; Biasiotto, R.; Borsche, M.; Brüggemann, N.; De Grandi, A.; Goegele, M.; Frygner-Holm, S.; Klein, C.; Kösters, M.; Staunton, C.; et al. Balancing Scientific Interests and the Rights of Participants in Designing a Recall by Genotype Study. Eur. J. Hum. Genet. 2021, 29, 1146–1157. [Google Scholar] [CrossRef] [PubMed]
- Staunton, C.; Kösters, M.; Pramstaller, P.P.; Mascalzoni, D. Return of Research Results (RoRR) to the Healthy CHRIS Cohort: Designing a Policy with the Participants. J. Community Genet. 2021, 12, 577–592. [Google Scholar] [CrossRef] [PubMed]
Approach | Action |
---|---|
Targeted interventions and technological development | Intervention development, new tools, therapies |
Stakeholder collaboration and data sharing | Partnerships, secure data platform |
Public engagement and research | Awareness, ethics, ongoing research |
Monitoring | Progress framework, patient outcomes |
Infrastructure | Development Requirements |
---|---|
Research and development facilities | Maintain and upgrade existing research facilities with state-of-the-art equipment and technologies to facilitate cutting-edge research in genomics, proteomics, metabolomics, and other areas relevant to precision medicine. |
Diagnostic and laboratory facilities | Upgrade and reorganize existing diagnostic and laboratory facilities to accommodate advanced genetic testing, biomarker identification, and other diagnostic procedures relevant to precision medicine |
Biobanking | Upgrade the existing biobank for the collection, storage, and analysis of biological samples and health data from the South Tyrolean population |
Management and analytics capabilities | Develop secure data management systems and analytics platforms to store, analyze, and share large volumes of health data, including genomic, clinical, and lifestyle information |
Telemedicine and digital health infrastructure | Invest in telemedicine solutions and digital health tools to enhance access to specialized care and expertise, especially for patients in remote areas or with limited transportation options |
Health information exchange and electronic health records | Implement a health information exchange system that allows for the seamless sharing of electronic health records among healthcare providers and institutions, enabling more efficient and personalized care |
Education and training facilities | Expand facilities and programs dedicated to training healthcare professionals in precision medicine, including specialized courses, workshops, and seminars |
Network connectivity and broadband access | Ensure reliable network connectivity and broadband access throughout the region, enabling the efficient use of telemedicine, digital health tools, and data management systems |
Public awareness and education infrastructure | Expand infrastructure for public education and awareness campaigns, such as community centers or digital platforms, to promote understanding and engagement with precision medicine initiatives |
Monitoring and evaluation systems | Establish robust monitoring and evaluation systems to assess the impact of the precision medicine program on patient outcomes, healthcare costs, and overall population health, which can inform future investments and adjustments |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Wiedermann, C.J. Advancing Precision Medicine in South Tyrol, Italy: A Public Health Development Proposal for a Bilingual, Autonomous Province. J. Pers. Med. 2023, 13, 972. https://doi.org/10.3390/jpm13060972
Wiedermann CJ. Advancing Precision Medicine in South Tyrol, Italy: A Public Health Development Proposal for a Bilingual, Autonomous Province. Journal of Personalized Medicine. 2023; 13(6):972. https://doi.org/10.3390/jpm13060972
Chicago/Turabian StyleWiedermann, Christian J. 2023. "Advancing Precision Medicine in South Tyrol, Italy: A Public Health Development Proposal for a Bilingual, Autonomous Province" Journal of Personalized Medicine 13, no. 6: 972. https://doi.org/10.3390/jpm13060972
APA StyleWiedermann, C. J. (2023). Advancing Precision Medicine in South Tyrol, Italy: A Public Health Development Proposal for a Bilingual, Autonomous Province. Journal of Personalized Medicine, 13(6), 972. https://doi.org/10.3390/jpm13060972